2023 annual financial data
Odyssey Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -10,870.59%.
Operating income was -133,439,000 USD and net income was -125,938,000 USD.
Operating cash flow was -112,728,000 USD.
Get free Odyssey Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,037,000 USD
- Operating income
- -133,439,000 USD
- Net income
- -125,938,000 USD
- Operating cash flow
- -112,728,000 USD